Managerial and Decision Economics

Cover image for Managerial and Decision Economics

Special Issue: Economic and Policy Issues in the Pharmaceutical Industry

June - August 2007

Volume 28, Issue 4-5

Pages 229–522

Issue edited by: John A. Vernon, Richard L Manning

  1. Editorials

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Commentaries
    5. Research Articles
    6. Commentaries
    7. Research Articles
    8. Commentaries
    9. Research Articles
    10. Commentaries
    11. Research Articles
    12. Commentaries
    13. Research Articles
    14. Commentaries
    15. Research Articles
    16. Book Reviews
    1. Editorial (page 229)

      John A. Vernon and Richard L Manning

      Version of Record online: 17 AUG 2007 | DOI: 10.1002/mde.1336

  2. Research Articles

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Commentaries
    5. Research Articles
    6. Commentaries
    7. Research Articles
    8. Commentaries
    9. Research Articles
    10. Commentaries
    11. Research Articles
    12. Commentaries
    13. Research Articles
    14. Commentaries
    15. Research Articles
    16. Book Reviews
    1. Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion (pages 231–250)

      Ernst R. Berndt, Patricia M. Danzon and Gregory B. Kruse

      Version of Record online: 17 AUG 2007 | DOI: 10.1002/mde.1338

  3. Commentaries

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Commentaries
    5. Research Articles
    6. Commentaries
    7. Research Articles
    8. Commentaries
    9. Research Articles
    10. Commentaries
    11. Research Articles
    12. Commentaries
    13. Research Articles
    14. Commentaries
    15. Research Articles
    16. Book Reviews
    1. Commentary (pages 285–291)

      Joseph A. DiMasi

      Version of Record online: 17 AUG 2007 | DOI: 10.1002/mde.1341

  4. Research Articles

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Commentaries
    5. Research Articles
    6. Commentaries
    7. Research Articles
    8. Commentaries
    9. Research Articles
    10. Commentaries
    11. Research Articles
    12. Commentaries
    13. Research Articles
    14. Commentaries
    15. Research Articles
    16. Book Reviews
    1. Mergers and acquisitions in the pharmaceutical and biotech industries (pages 307–328)

      Patricia M. Danzon, Andrew Epstein and Sean Nicholson

      Version of Record online: 17 AUG 2007 | DOI: 10.1002/mde.1343

  5. Commentaries

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Commentaries
    5. Research Articles
    6. Commentaries
    7. Research Articles
    8. Commentaries
    9. Research Articles
    10. Commentaries
    11. Research Articles
    12. Commentaries
    13. Research Articles
    14. Commentaries
    15. Research Articles
    16. Book Reviews
    1. Commentary (pages 353–355)

      Joseph Golec

      Version of Record online: 17 AUG 2007 | DOI: 10.1002/mde.1345

  6. Research Articles

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Commentaries
    5. Research Articles
    6. Commentaries
    7. Research Articles
    8. Commentaries
    9. Research Articles
    10. Commentaries
    11. Research Articles
    12. Commentaries
    13. Research Articles
    14. Commentaries
    15. Research Articles
    16. Book Reviews
    1. Determinants of drug prices and expenditures (pages 357–370)

      William S. Comanor and Stuart O. Schweitzer

      Version of Record online: 17 AUG 2007 | DOI: 10.1002/mde.1346

  7. Commentaries

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Commentaries
    5. Research Articles
    6. Commentaries
    7. Research Articles
    8. Commentaries
    9. Research Articles
    10. Commentaries
    11. Research Articles
    12. Commentaries
    13. Research Articles
    14. Commentaries
    15. Research Articles
    16. Book Reviews
  8. Research Articles

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Commentaries
    5. Research Articles
    6. Commentaries
    7. Research Articles
    8. Commentaries
    9. Research Articles
    10. Commentaries
    11. Research Articles
    12. Commentaries
    13. Research Articles
    14. Commentaries
    15. Research Articles
    16. Book Reviews
  9. Commentaries

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Commentaries
    5. Research Articles
    6. Commentaries
    7. Research Articles
    8. Commentaries
    9. Research Articles
    10. Commentaries
    11. Research Articles
    12. Commentaries
    13. Research Articles
    14. Commentaries
    15. Research Articles
    16. Book Reviews
    1. Commentary (pages 437–438)

      Tomas J. Philipson

      Version of Record online: 17 AUG 2007 | DOI: 10.1002/mde.1350

  10. Research Articles

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Commentaries
    5. Research Articles
    6. Commentaries
    7. Research Articles
    8. Commentaries
    9. Research Articles
    10. Commentaries
    11. Research Articles
    12. Commentaries
    13. Research Articles
    14. Commentaries
    15. Research Articles
    16. Book Reviews
    1. Entry and competition in generic biologics (pages 439–451)

      Henry G. Grabowski, David B. Ridley and Kevin A. Schulman

      Version of Record online: 17 AUG 2007 | DOI: 10.1002/mde.1352

  11. Commentaries

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Commentaries
    5. Research Articles
    6. Commentaries
    7. Research Articles
    8. Commentaries
    9. Research Articles
    10. Commentaries
    11. Research Articles
    12. Commentaries
    13. Research Articles
    14. Commentaries
    15. Research Articles
    16. Book Reviews
    1. Commentary (pages 453–454)

      Tomas J. Philipson

      Version of Record online: 17 AUG 2007 | DOI: 10.1002/mde.1353

  12. Research Articles

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Commentaries
    5. Research Articles
    6. Commentaries
    7. Research Articles
    8. Commentaries
    9. Research Articles
    10. Commentaries
    11. Research Articles
    12. Commentaries
    13. Research Articles
    14. Commentaries
    15. Research Articles
    16. Book Reviews
  13. Commentaries

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Commentaries
    5. Research Articles
    6. Commentaries
    7. Research Articles
    8. Commentaries
    9. Research Articles
    10. Commentaries
    11. Research Articles
    12. Commentaries
    13. Research Articles
    14. Commentaries
    15. Research Articles
    16. Book Reviews
    1. Commentary (pages 467–468)

      Tomas J. Philipson

      Version of Record online: 17 AUG 2007 | DOI: 10.1002/mde.1357

  14. Research Articles

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Commentaries
    5. Research Articles
    6. Commentaries
    7. Research Articles
    8. Commentaries
    9. Research Articles
    10. Commentaries
    11. Research Articles
    12. Commentaries
    13. Research Articles
    14. Commentaries
    15. Research Articles
    16. Book Reviews
    1. The cost of biopharmaceutical R&D: is biotech different? (pages 469–479)

      Joseph A. DiMasi and Henry G. Grabowski

      Version of Record online: 17 AUG 2007 | DOI: 10.1002/mde.1360

    2. Benefits and costs of newer drugs: an update (pages 485–490)

      Frank R. Lichtenberg

      Version of Record online: 17 AUG 2007 | DOI: 10.1002/mde.1355

  15. Book Reviews

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Commentaries
    5. Research Articles
    6. Commentaries
    7. Research Articles
    8. Commentaries
    9. Research Articles
    10. Commentaries
    11. Research Articles
    12. Commentaries
    13. Research Articles
    14. Commentaries
    15. Research Articles
    16. Book Reviews

SEARCH

SEARCH BY CITATION